Parametrica Management LTD Pacira Bio Sciences, Inc. Transaction History

Parametrica Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$51.97 - $63.0 $272,790 - $330,687	-5,249 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$30.8 - $52.47 $161,669 - $275,415	5,249 New	5,249 $275,000
Q1 2019 May 07, 2019	SELL	$36.47 - $42.17 $233,335 - $269,803	-6,398 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$41.31 - $52.16 $47,010 - $59,358	1,138 Added 21.63%	6,398 $275,000
Q3 2018 Nov 06, 2018	BUY	$32.85 - $52.0 $172,791 - $273,520	5,260 New	5,260 $259,000

302

51.6M

378K

1.53M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $701M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Parametrica Management LTD, based on Form 13F filings with the SEC.

Stay updated on Parametrica Management LTD with notifications on news.